- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Surya Pharma properties worth Rs 185 crore attached by ED
Overview
The Directorate of Enforcement (ED) has attached properties worth Rs 185.1 crore belonging to Surya Pharmaceuticals Ltd in a money laundering case.
The attached properties include building, plant, and machinery, the ED said in a statement on Tuesday.
The enforcement agency has taken the action under the Prevention of Money Laundering Act (PMLA), 2002.
ED initiated an investigation under the provisions of PMLA, 2002 on the basis of 2 FIRs registered by CBI on the complaint of State Bank of India, Chandigarh, and Punjab and Sind Bank, Karnal against Surya Pharmaceuticals Ltd, its Managing Director Rajiv Goyal and others for defrauding the banks to the tune of Rs 828 crore.
For more details, check out the link given below:
Money Laundering Case: Surya Pharma Properties Worth Rs 185 Crore Attached By ED